Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sun Pharma Advanced Research Company Limited
Age
18–55
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
1. Availability of volunteer for the entire study period and willingness to adhere to protocol requirements as evidenced by written informed consent.
2. Patients with metastatic breast cancer/advanced ovarian cancer having age within the range of between 18-55 years.
3. Subjects who had no evidence of underlying disease
4. Subjects who had signed written consent form
You may not be if
1. Females who were pregnant, breastfeeding, or are likely to become pregnant
2. Subjects who had any medical condition (except metastatic breast cancer/advanced ovarian cancer) that could jeopardize their health or prejudice the results
3. Subjects deemed uncooperative or noncompliant
4. Smoking or consumption of any nicotine products
Clareo Health | Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer
